Coefficient | SE | P* | |
African-American patients with SLE† | |||
Anti-dsDNA | 15.274 | 7.375 | 0.040 |
Anti-Sm | 23.932 | 7.464 | 0.002 |
APL | 30.138 | 11.439 | 0.009 |
Hispanic-American patients with SLE† | |||
Anti-La | 91.002 | 26.164 | 0.001 |
Anti-RNP | 43.586 | 13.547 | 0.002 |
European-American patients with SLE patients† | |||
Anti-RNP | 35.680 | 13.610 | 0.010 |
*P value <0.05 was considered significant.
†APL, anti-Ro/La, anti-Sm, anti-RNP and anti-dsDNA antibodies were included in the stepwise multivariate regression analysis.
APL, antiphospholipid; anti-dsDNA, antidouble-stranded DNA; anti-RNP, antiribonucleoprotein; SLE, systemic lupus erythematosus.